Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights July–September 2021.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 12, doi. 10.1093/ajhp/zxab433
- Publication type:
- Article
Works matching IS 10792082 AND DT 2022 AND VI 79 AND IP 2
Results: 17
1
2
Lessons from pandemic bolster response to weather emergency.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 10, doi. 10.1093/ajhp/zxab435
- By:
- Publication type:
- Article
3
Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights July–September 2021.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. e90, doi. 10.1093/ajhp/zxab433
- Publication type:
- Article
4
California pharmacist Mary Patricia Lee dies at 87.
- Published in:
- 2022
- By:
- Publication type:
- Obituary
5
Pharmacy Forecast report: Planning or preparedness?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
6
Ruxolitinib Phosphate.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 6, doi. 10.1093/ajhp/zxab396
- Publication type:
- Article
7
other side of "challenging learners": Strategies for teaching and precepting the overachiever and high performer.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 17, doi. 10.1093/ajhp/zxab348
- By:
- Publication type:
- Article
8
Mobocertinib Succinate.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 3, doi. 10.1093/ajhp/zxab395
- Publication type:
- Article
9
Avoiding cost avoidance.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
10
Evaluation of rates of virologic suppression in HIV-positive patients with varying numbers of comorbidities.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 72, doi. 10.1093/ajhp/zxab346
- By:
- Publication type:
- Article
11
Pharmacotherapy review: Emerging treatment modalities in transthyretin cardiac amyloidosis.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 52, doi. 10.1093/ajhp/zxab356
- By:
- Publication type:
- Article
12
ASHP Foundation Pharmacy Forecast 2022: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 23, doi. 10.1093/ajhp/zxab355
- By:
- Publication type:
- Article
13
Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 78, doi. 10.1093/ajhp/zxab363
- By:
- Publication type:
- Article
14
Roadblocks and successes in preparing COVID-19 vaccination clinics: Perspectives from pharmacy residents.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 102, doi. 10.1093/ajhp/zxab347
- By:
- Publication type:
- Article
15
Response to Murray et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
16
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 63, doi. 10.1093/ajhp/zxab344
- By:
- Publication type:
- Article
17
Caregiver and provider perspectives on dual VA and Medicare Part D medication use in veterans with suspected dementia or cognitive impairment.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 2, p. 94, doi. 10.1093/ajhp/zxab343
- By:
- Publication type:
- Article